New Real World Evidence Shows that Long-acting Antipsychotics Reduce Risk of Mortality for Patients Living with Schizophrenia Compared to Oral Antipsychotics

January 17, 2018

Responsive image

BEERSE, Belgium, January 18, 2018 /PRNewswire/ —
The Janssen Pharmaceutical Companies of Johnson & Johnson announce results of new real world evidence from a study of almost 30,000 people, which supports the benefits of long-acting antipsychotics (LATs) in reducing the risk of…

Category: Precious Metals